eF-site ID 6skl-234567ABCDEFGHXY PDB Code 6skl Chain 2, 3, 4, 5, 6, 7, A, B, C, D, E, F, G, H, X, Y Title Cryo-EM structure of the CMG Fork Protection Complex at a replication fork - Conformation 1 Classification REPLICATION Compound DNA replication licensing factor MCM2 Source (CSM3_YEAST) Sequence 2:  DIDPLREELTLESLSNVKANSYSEWITQPNVSRTIARELK SFLLEYTDETGRSVYGARIRTLGEMNSESLEVNYRHLAES KAILALFLAKCPEEMLKIFDLVAMEATELHYPDYARIHSE IHVRISDFPTIYSLRELRESNLSSLVRVTGVVTRRTGVFP QLKYVKFNCLKCGSILGPFFQDSNEEIRISFCTNCKSKGP FRVNGEKTVYRNYQRVTLQEAPGTVPPGRLPRHREVILLA DLVDVSKPGEEVEVTGIYKNNYDGNLNAKNGFPVFATIIE ANSIKRREGNTANEGEEGLDVFSWTEEEEREFRKISRDRG IIDKIISSMAPSIYGHRDIKTAVACSLFGGVPKNVNGKHS IRGDINVLLLGDPGTAKSQILKYVEKTAHRAVFATGQGAS AVGLTASVRKDPITKEWTLEGGALVLADKGVCLIDEFDKM NDQDRTSIHEAMEQQSISISKAGIVTTLQARCSIIAAANP NGGRYNSTLPLAQNVSLTEPILSRFDILCVVRDLVDEEAD ERLATFVVDSHVRSHPENLNARQRRLQRQRKKEEEISPIP QELLMKYIHYARTKIYPKLHQMDMDKVSRVYADLRRESIS TGSFPITVRHLESILRIAESFAKMRLSEFVSSYDLDRAIK VVVDSFVDAQKVSVRRQLRRSFAIYTLGH 3:  DAVFGDRVRRFQEFLDTFTSYRDSVRSIQVYNSNNAANYN ILPHRIIISLDDLREFDRSFWSGILVEPAYFIPPAEKALT DLADSMDDVPHPNASAVSSRHPWKLSFKGSFGAHALSPRT LTAQHLNKLVSVEGIVTKTSLVRPKLIRSVHYAAKTGRFH YRDYTDATTTLTTRIPTPAIYPTEDTEGNKLTTEYGYSTF IDHQRITVQEMPEMAPAGQLPRSIDVILDDDLVDKTKPGD RVNVVGVFKSLGAGGMNQSNSNTLIGFKTLILGNTVYPLH ARAARQMLTDFDIRNINKLSKKKDIFDILSQSLAPSIYGH DHIKKAILLMLMGGVEKNLENGSHLRGDINILMVGDPSTA KSQLLRFVLNTASLAIATTGRGSSGVGLTAAVTTDRETGE RRLEAGAMVLADRGVVCIDEFDKMTDVDRVAIHEVMEQQT VTIAKAGIHTTLNARCSVIAAANPVFGQYDVNRDPHQNIA LPDSLLSRFDLLFVVTDDINEIRDRSISEHVLRTHRYLPP GYLEGEPVRPKLVTIPFLRKYVQYAKERVIPQLTQEAINV IVKNYTDLRNDPITARTLETLIRLATAHAKVRLSKTVNKV DAKVAANLLRFALLGE 4:  SEPLRIIWGTNVSIQECTTNFRNFLMSFKYKFRKILDERE EFINNTTDEELYYIKQLNEMRELGTSNLNLDARNLLAYKQ TEDLYHQLLNYPQEVISIMDQTIKDCMVSLIVDNNLDYDL DEIETKFYKVRPYNVGSCKGMRELNPNDIDKLINLKGLVL RSTPVIPDMKVAFFKCNVCDHTMAVEIDRGVIQEPARCER IDCNEPNSMSLIHNRCSFADKQVIKLQETPDFVPDGQTPH SISLCVYDELVDSCRAGDRIEVTGTFRSIPIRANSRQRVL KSLYKTYVDVVHVKKVDLAKIREVAAREDLYSLLARSIAP SIYELEDVKKGILLQLFGGTNKTFRYRGDINILLCGDPST SKSQILQYVHKITPRGVYTSGKGSSAVGLTAYITRVLESG ALVLSDGGVCCIDEFDKMSDSTRSVLHEVMEQQTISIAKA GIITTLNARSSILASANPIGSRYNPNLPVTENIDLPPPLL SRFDLVYLVLDKVDEKNDRELAKHLTNLYLEDVLPVEFLT MYISYAKEHIHPIITEAAKTELVRAYVGMRKMTATTRQLE SMIRLAEAHAKMKLKNVVELEDVQEAVRLIRSAIKDKIDM NLVQTGKSVIQRKLQEDLSREIMNVLKDQASDSMSFNELI KQINEHSQDRVESSDIQEALSRLQQEDKVIVLGGVRRSV 5:  NDDDNTEIIKSFKNFILEFRLDSQFIYRDQLRNNILVKNY SLTVNMEHLIGYNEDIYKKLSDEPSDIIPLFETAITQVAK RISILSRASLPTFQLILNSNANQIPLRDLDSEHVSKIVRL SGIIISTSVLSSRATYLSIMCRNCRHTTSITINNFNVSLP RSCLSNCGPDPYIIIHESSKFIDQQFLKLQEIPELVPVGE MPRNLTMTCDRYLTNKVIPGTRVTIVGIYSIYNSKNGVAI RTPYIKILGIQSDVETSSIWNSVTMFTEEEEEEFLQLSRN PKLYEILTNSIAPSIFGNEDIKKAIVCLLMGGSKKILPDG MRLRGDINVLLLGDPGTAKSQLLKFVEKVSPIAVYTSGKG SSAAGLTASVQRDPMTREFYLEGGAMVLADGGVVCIDEFD KMRDEDRVAIHEAMEQQTISIAKAGITTVLNSRTSVLAAA NPIYGRYDDLKSPGDNIDFQTTILSRFDMIFIVKDDHNEE RDISIANHVINIHTGNANAMQNQQEENGSEISIEKMKRYI TYCRLKCAPRLSPQAAEKLSSNFVTIRKQLLINELESTER SSIPITIRQLEAIIRITESLAKLELSPIAQERHVDEAIRL FQASTMDAASQ 6:  SFKSRALNHVKKVDDVTGEKVREAFEQFLEDFSVQSTDTG EVEKVYRAQIEFMKIYDLNTIYIDYQHLSMRENGALAMAI SEQYYRFLPFLQKGLRRVVRKYAPELLNTSSPEQTERVFQ ISFFNLPTVHRIRDIRSEKIGSLLSISGTVTRTSEVRPEL YKASFTCDMCRAIVDNVEQSFKYTEPTFCPNPSCENRAFW TLNVTRSRFLDWQKVRIQENANEIPTGSMPRTLDVILRGD SVERAKPGDRCKFTGVEIVVPDVTQLGLPGVKPSSNSGVT GLRSLGVRDLTYKISFLACHVISIGNERDQEVFLNSLSSD EINELKEMVKDEHIYDKLVRSIAPAVFGHEAVKKGILLQM LGGVHKSTVEGIKLRGDINICVVGDPSTSKSQFLKYVVGF APRSVYTSGKASSAAGLTAAVVRDDYTIEAGALMLADNGI CCIDEFDKMDISDQVAIHEAMEQQTISIAKAGIHATLNAR TSILAAANPVGGRYNRKLSLRGNLNMTAPIMSRFDLFFVI LDDCNEKIDTELASHIVDLHMKPPFSAEQLRRYIKYARTF KPILTKEARSYLVEKYKELRKDDAQGFSRSSYRITVRQLE SMIRLSEAIARANCVDEITPSFIAEAYDLLRQSIIRV 7:  ALPSIQLPVDYNNLFNEITDFLVTFKQDTLSGPKYMAMLQ KVANRELNSVIIDLDDILQYQNEKFLQGTQADDLVSAIQQ NANHFTELFCRAIDNNMPLPTKEIDYKDDVLDVILNQRRL RNERMLSDRELFPPNLTRRYFLYFKPLSQNAISSKPLSVR QIKGDFLGQLITVRGIITRVSDVKPAVEVIAYTCDQCGYE VFQEVNSRTFTPLSECTSEECSQNQTKGQLFMSTRASKFS AFQECKIQELSQQVPVGHIPRSLNIHVNGTLVRSLSPGDI VDVTGIFLPAPYTGFKALKAGLLTETYLEAQFVRQHKDVE ERVMELITSGDVYNRLAKSIAPEIYGNLDVKKALLLLLVG GVDKRKIRGDINVCLMGDPGVAKSQLLKAICKISPRGVYT TGKLTAAVMKDPVTDEMILEGGALVLADNGICCIDEFDKM DESDRTAIHEVMEQQTISISKAGINTTLNARTSILAAANP LYGRYNPRLSPLDNINLPAALLSRFDILFLMLDIPSRDDD EKLAEHVTYVHMHNKQPDLDFTPVEPSKMREYIAYAKTKR PVMSEAVNDYVVQAYIRLRQDSKRFSFGQATPRTLLGIIR LSQALAKLRLADMVDIDDVEEALRLVRVSKESLYQ A:  MYGDLGNKLVLEAKRTKQLYARSNQDVNLPMYHEDIIRNI LKEVSNLRKNTEYLKEQQQLGMLDDKVAKCQYFVTLLCME RNKRCLLAYQRLRTDILDSMAWNNNGLDTNNLSHQEQEYL KEYCDLITDLKSGDLVDIDLSGSLVPPSDVFIDVRVLKDA GEIQTEYGVFNLIKDSQFFVRQSDVERLIQQGYLQKI B:  MSLPAHLQQTFSPEEIQFIVENEPIKIFPRITTRQKIRHT RWQLITTDDKALNNMVAMRSTEVVLWIALLLKQQSKCSIV APQWLTTKELDRKIQYEKTHPDRFSELPWNWLVLARILFN KAKDDFHDPIHELRGKIQDLREIRQIKVLKGLKYLNESHL QLDNLSLLEINELRPFITEIMDKLREIHTASLT C:  SHMASMGYYDIDDVLADGTEFPCKFQYDIPGLGYLENNPG RPITKNTKLSLPLWLARILAIVGPVPFVELLPPDMFSTKV MNAIKTDPVALDLHSINSHFFSLAIKWIMLFSEKELANVV SELLLQRAQELNHHASSLSITNIATSTFLLKLEEMEKEIY KKSHESYKDTKRWMFKK D:  DINIDDILAELDKEVSPQQDFSDLMKSWKNERCSPELLPY PHQLMKRLLNRISMQSQLIENISMGFLDNESKLPLLCMET ELERLKFVIRSYIRCRLSKIDKFSLYLRQLNEDENSLISL TDLLSKDEIKYHDTHSLIWLKLVNDSILKYMPEELQAIND TEGSVNMIDEPDWNKFVFIHVNGPPDGKWNEDPLLQENEF GKPCYTVTIPDLKEEVELTIGSIYVMRYEVIRDLLRDDKV ALI E:  MYYGISQFSEAYNKILRNSSSHSSCQLVIFVSCLNIDALC ATKMLSLLFKKQLVQSQIVPIFGYSELRRHYSQLDDNINS LLLVGFGGVIDLEAFLEIDPQEYVIDTDSGEQSFRRDIYV LDAHRPWNLDNIFGSQIIQCFDDGTVDDTLGEQKEAYYKL LELDRKQRKKQIHEYEGVLEEYYSQGTTVVNSISAQIYSL LSAIGETNLSNLWLNILGTTSLDIAYAQVYNRLYPLLQDE VKRLTPSSRNSVKTPDTLTLNIQPDYYLFLLRHSSLYDSF YYSNYVNAKLSLWNENGKKRLHKMFARMGIPLSTAQETWL YMDHSIKRELGIIFDKNLDRYGLQDIIRDGFVRTLGYRGS ISASEFVEALTALLEVGNNSAQKLTNLRKRWVSNFWLSWD ALDDRKVELLNRGIQLAQDLQRAIFNTGVAILEKKLIKHL RIYRLCVLQDGPDLDLYRNPLTLLRLGNWLIECCAESEDK QLLPMVLASIDENTDTYLVAGLTPRYPRGLDKKPILNNFS MAFQQITAETDAKVRIDNFESSIIEIRREDLSPFLEKLTL SGLL F:  KFRYMPFSPAGTPFGFTDRRYLTMNEVGYVSTVKNSEQYS ITVSFFDVGRFREYHFEDLFGYDLCFLNEKGTLFGQSKTG QIQYRPHDSIHSNWTKIIPLQAGERITSVAATPVRVIVGT SLGYFRSFNQFGVPFAVEKTSPIVALTAQNYRVFSVHYSQ FHGLSYSLSELGTSSKRYYKRECPLPMSLPNIKDANLDYY NFNPMGIKSLFFSSYGDPCIFGSDNTLLLLSKWRSPEESK WLPILDSNMEIWKMSGGKETTDIHVWPLALAYDTLNCILV KGKHIWPEFPLPLPSEMEIRMPVFVKSKLLEENKEIQIPV SMAAEEEYLRSKVLSELLTDTLENDGEMYGNENEVLAALN GAYDKALLRLFASACSDQNVEKALSLAHELKQDRALTAAV KISERAELPSLVKKINNIREARYE G:  FRYMPFSPAGTPFGFTDRRYLTMNEVGYVSTVKNSEQYSI TVSFFDVGRFREYHFEDLFGYDLCFLNEKGTLFGQSKTGQ IQYRPHDSIHSNWTKIIPLQAGERITSVAATPVRVIVGTS LGYFRSFNQFGVPFAVEKTSPIVALTAQNYRVFSVHYSQF HGLSYSLSELGTSSKRYYKRECPLPMSLPNKDANLDYYNF NPMGIKSLFFSSYGDPCIFGSDNTLLLLSKWRSPEESKWL PILDSNMEIWKMSGGKETTDIHVWPLALAYDTLNCILVKG KHIWPEFPLPLPSEMEIRMPVFVKSKLLEENEIQIPVSMA AEEEYLRSKVLSELLTDTLENDGEMYGNENEVLAALNGAY DKALLRLFASACSDQNVEKALSLAHELKQDRALTAAVKIS ERAELPSLVKKINNIREARYEQ H:  KFRYMPFSPAGTPFGFTDRRYLTMNEVGYVSTVKNSEQYS ITVSFFDVGRFREYHFEDLFGYDLCFLNEKGTLFGQSKTG QIQYRPHDSIHSNWTKIIPLQAGERITSVAATPVRVIVGT SLGYFRSFNQFGVPFAVEKTSPIVALTAQNYRVFSVHYSQ FHGLSYSLSELGTSSKRYYKRECPLPMSLPNINKDANLDY YNFNPMGIKSLFFSSYGDPCIFGSDNTLLLLSKWRSPEES KWLPILDSNMEIWKMSGGKETTDIHVWPLALAYDTLNCIL VKGKHIWPEFPLPLPSEMEIRMPVFVKSKLLEENEIQIPV SMAAEEEYLRSKVLSELLTDTLENDGEMYGNENEVLAALN GAYDKALLRLFASACSDQNVEKALSLAHELKQDRALTAAV KISERAELPSLVKKINNIREARYEQ X:  ADFSLTVLRARIALLATAIGGPDYTPPYKLGDDCLACLKD LKRWFKLVDDQQKRWDVAMAVAEYRILTDDLLPILIDWEN KCSLAAKLANKAYYDKIALNCLQLLVLMTWPLIVTEQSSS NQITLYGELKKHQLVYKKTILSMESGKVLRAAIRLALDVI KIDRLSRTPRDNMVLKLVLNFFRNVIAIEPGEFTINTKKS MPKKGITSIDTLPPNVSMDDISLNTVISSFHKNKVFGFLL TLTSSLSDFINIPLLEIMFYFTKDVNQELLFPRTSAGFEL SKLLQKEHQMRKNVIKHTSARHSRFGGLLSIQTPDKTRLT VSGSQALVDEKIALQKLDDSKKWNKRIIKKEGLPNSLLNS QTGKAIFFTESNGKHFKEFINNFIDSGFNILLHSVTNYFT TEQDRMVTLEQVEYLLFFAWFVKYQLLRSKIDNSADIKQV SEALKEVTFILVSSLLRSAYDLKNWTVTHAGMIAFNELLN LVSRTKAAQDIEFIVSRLFSDERIQLLSNLPKIGSKYSLQ FMKSCIELTHSVLKVLEQYSVNFQKVQANYMTEPVIETYI NFLERFRELEDDSIKKVFSFFHRVFVQAKEQALLFRFDLI ILLREMLSPDGLDRMSRSRKYVSQFSDYFLARLKKRLKKS PAWFVGLLFPPLHNSEVGFYQRYGE Y:  RKRRPQVKLTAEKLLSDKGLPYVLKNAHKRIRISSKKNSY DNLSNIIQFYQLWAHELFPKAKFKDFMKICQTVGKTDPVL REYRVSLFRDEMGM Description (1)  Cell division control protein 45, DNA polymerase alpha-binding protein, DNA replication complex GINS protein PSF1, DNA replication complex GINS protein PSF2, DNA replication complex GINS protein SLD5, DNA replication licensing factor MCM2, DNA replication licensing factor MCM3, Minichromosome maintenance protein 5, DNA replication licensing factor MCM6, DNA replication licensing factor MCM4, DNA replication licensing factor MCM7, DNA replication complex GINS protein PSF3, Topoisomerase 1-associated factor 1, Chromosome segregation in meiosis protein 3/DNA Complex Functional site 1) chain 2 residue 341 type sequence C description binding site for residue ZN 2 901 source : AC1 2) chain 2 residue 344 type sequence C description binding site for residue ZN 2 901 source : AC1 3) chain 2 residue 364 type sequence C description binding site for residue ZN 2 901 source : AC1 4) chain 2 residue 367 type sequence C description binding site for residue ZN 2 901 source : AC1 5) chain 2 residue 506 type sequence Y description binding site for residue ANP 2 902 source : AC2 6) chain 2 residue 508 type sequence H description binding site for residue ANP 2 902 source : AC2 7) chain 2 residue 545 type sequence P description binding site for residue ANP 2 902 source : AC2 8) chain 2 residue 546 type sequence G description binding site for residue ANP 2 902 source : AC2 9) chain 2 residue 547 type sequence T description binding site for residue ANP 2 902 source : AC2 10) chain 2 residue 548 type sequence A description binding site for residue ANP 2 902 source : AC2 11) chain 2 residue 549 type sequence K description binding site for residue ANP 2 902 source : AC2 12) chain 2 residue 550 type sequence S description binding site for residue ANP 2 902 source : AC2 13) chain 2 residue 551 type sequence Q description binding site for residue ANP 2 902 source : AC2 14) chain 2 residue 651 type sequence N description binding site for residue ANP 2 902 source : AC2 15) chain 2 residue 695 type sequence L description binding site for residue ANP 2 902 source : AC2 16) chain 2 residue 699 type sequence V description binding site for residue ANP 2 902 source : AC2 17) chain 6 residue 657 type sequence E description binding site for residue ANP 2 902 source : AC2 18) chain 6 residue 658 type sequence Q description binding site for residue ANP 2 902 source : AC2 19) chain 6 residue 708 type sequence R description binding site for residue ANP 2 902 source : AC2 20) chain 6 residue 797 type sequence V description binding site for residue ANP 2 902 source : AC2 21) chain 6 residue 798 type sequence R description binding site for residue ANP 2 902 source : AC2 22) chain 6 residue 801 type sequence E description binding site for residue ANP 2 902 source : AC2 23) chain 2 residue 550 type sequence S description binding site for residue MG 2 903 source : AC3 24) chain 3 residue 372 type sequence Y description binding site for residue ANP 3 1500 source : AC4 25) chain 3 residue 411 type sequence P description binding site for residue ANP 3 1500 source : AC4 26) chain 3 residue 412 type sequence S description binding site for residue ANP 3 1500 source : AC4 27) chain 3 residue 413 type sequence T description binding site for residue ANP 3 1500 source : AC4 28) chain 3 residue 414 type sequence A description binding site for residue ANP 3 1500 source : AC4 29) chain 3 residue 415 type sequence K description binding site for residue ANP 3 1500 source : AC4 30) chain 3 residue 416 type sequence S description binding site for residue ANP 3 1500 source : AC4 31) chain 3 residue 417 type sequence Q description binding site for residue ANP 3 1500 source : AC4 32) chain 3 residue 517 type sequence N description binding site for residue ANP 3 1500 source : AC4 33) chain 3 residue 565 type sequence V description binding site for residue ANP 3 1500 source : AC4 34) chain 5 residue 498 type sequence E description binding site for residue ANP 3 1500 source : AC4 35) chain 5 residue 499 type sequence Q description binding site for residue ANP 3 1500 source : AC4 36) chain 5 residue 549 type sequence R description binding site for residue ANP 3 1500 source : AC4 37) chain 5 residue 650 type sequence I description binding site for residue ANP 3 1500 source : AC4 38) chain 5 residue 651 type sequence R description binding site for residue ANP 3 1500 source : AC4 39) chain 5 residue 654 type sequence E description binding site for residue ANP 3 1500 source : AC4 40) chain 3 residue 416 type sequence S description binding site for residue MG 3 1501 source : AC5 41) chain 4 residue 349 type sequence C description binding site for residue ZN 4 1400 source : AC6 42) chain 4 residue 352 type sequence C description binding site for residue ZN 4 1400 source : AC6 43) chain 4 residue 371 type sequence C description binding site for residue ZN 4 1400 source : AC6 44) chain 4 residue 376 type sequence C description binding site for residue ZN 4 1400 source : AC6 45) chain 2 residue 531 type sequence H description binding site for residue ANP 5 801 source : AC7 46) chain 2 residue 625 type sequence E description binding site for residue ANP 5 801 source : AC7 47) chain 2 residue 626 type sequence Q description binding site for residue ANP 5 801 source : AC7 48) chain 2 residue 676 type sequence R description binding site for residue ANP 5 801 source : AC7 49) chain 2 residue 807 type sequence V description binding site for residue ANP 5 801 source : AC7 50) chain 2 residue 808 type sequence R description binding site for residue ANP 5 801 source : AC7 51) chain 2 residue 811 type sequence E description binding site for residue ANP 5 801 source : AC7 52) chain 5 residue 377 type sequence S description binding site for residue ANP 5 801 source : AC7 53) chain 5 residue 379 type sequence F description binding site for residue ANP 5 801 source : AC7 54) chain 5 residue 418 type sequence P description binding site for residue ANP 5 801 source : AC7 55) chain 5 residue 419 type sequence G description binding site for residue ANP 5 801 source : AC7 56) chain 5 residue 420 type sequence T description binding site for residue ANP 5 801 source : AC7 57) chain 5 residue 421 type sequence A description binding site for residue ANP 5 801 source : AC7 58) chain 5 residue 422 type sequence K description binding site for residue ANP 5 801 source : AC7 59) chain 5 residue 423 type sequence S description binding site for residue ANP 5 801 source : AC7 60) chain 5 residue 424 type sequence Q description binding site for residue ANP 5 801 source : AC7 61) chain 5 residue 524 type sequence N description binding site for residue ANP 5 801 source : AC7 62) chain 2 residue 676 type sequence R description binding site for residue MG 5 802 source : AC8 63) chain 5 residue 423 type sequence S description binding site for residue MG 5 802 source : AC8 64) chain 5 residue 183 type sequence C description binding site for residue ZN 5 803 source : AC9 65) chain 5 residue 186 type sequence C description binding site for residue ZN 5 803 source : AC9 66) chain 5 residue 211 type sequence C description binding site for residue ZN 5 803 source : AC9 67) chain 5 residue 236 type sequence C description binding site for residue ZN 5 803 source : AC9 68) chain 6 residue 311 type sequence C description binding site for residue ZN 6 1400 source : AD1 69) chain 6 residue 314 type sequence C description binding site for residue ZN 6 1400 source : AD1 70) chain 6 residue 333 type sequence C description binding site for residue ZN 6 1400 source : AD1 71) chain 6 residue 338 type sequence C description binding site for residue ZN 6 1400 source : AD1 72) chain 7 residue 262 type sequence C description binding site for residue ZN 7 1400 source : AD2 73) chain 7 residue 265 type sequence C description binding site for residue ZN 7 1400 source : AD2 74) chain 7 residue 284 type sequence C description binding site for residue ZN 7 1400 source : AD2 75) chain 7 residue 289 type sequence C description binding site for residue ZN 7 1400 source : AD2 76) chain 3 residue 468-476 type prosite sequence GVVCIDEFD description MCM_1 MCM family signature. GVVCIDEFD source prosite : PS00847 77) chain 7 residue 519-527 type prosite sequence GICCIDEFD description MCM_1 MCM family signature. GVVCIDEFD source prosite : PS00847 78) chain 5 residue 475-483 type prosite sequence GVVCIDEFD description MCM_1 MCM family signature. GVVCIDEFD source prosite : PS00847 79) chain 4 residue 627-635 type prosite sequence GVCCIDEFD description MCM_1 MCM family signature. GVVCIDEFD source prosite : PS00847 80) chain 6 residue 634-642 type prosite sequence GICCIDEFD description MCM_1 MCM family signature. GVVCIDEFD source prosite : PS00847 81) chain 2 residue 602-610 type prosite sequence GVCLIDEFD description MCM_1 MCM family signature. GVVCIDEFD source prosite : PS00847 82) chain 7 residue 593 type MOD_RES sequence R description Phosphoserine => ECO:0007744|PubMed:18407956 source Swiss-Prot : SWS_FT_FI1 83) chain 7 residue 687 type MOD_RES sequence R description Phosphoserine => ECO:0007744|PubMed:18407956 source Swiss-Prot : SWS_FT_FI1

Display surface Download Links